FeesSafety
Pluang+

New Aramchol lipid nanoparticle targets tumor fibrosis to boost liver and GI cancer treatment efficacy

Market News
16 Nov 2026, 15:00 WIB
PRNewsWire
View Source
Bullish
New Aramchol lipid nanoparticle targets tumor fibrosis to boost liver and GI cancer treatment efficacy

Eocene Ltd.'s subsidiary Galmed, in collaboration with Barcode Nanotech, developed a novel lipid nanoparticle (LNP) formulation of Aramchol aimed at targeting the tumor microenvironment (TME) in liver and gastrointestinal cancers. This new formulation selectively inhibits fibrosis-driving cells in the TME, potentially enhancing the effectiveness of immunotherapy and other standard treatments with minimal toxicity. Previous trials showed Aramchol's oral form improved liver fibrosis in NASH/MASH patients, and this LNP approach seeks to accelerate and improve those antifibrotic effects by redirecting the drug to the tumor site. This innovation could help overcome the fibrotic barrier that limits immunotherapy success, offering better outcomes for more patients.

The development of tumor microenvironment-targeted lipid nanoparticles formulation of Aramchol is the focus of this update, with Pluang's health sector showing mixed activity. Of 150 priced health-sector US stocks on Pluang, 67 rose and 61 fell as of Nov 16, 2026 19:13 WIB. Notable movers include Summit Therapeutics Inc (SMMT) at USD 12.16 with a -14.06% change, Abeona Therapeutics Inc (ABEO) at USD 2.28 down -5.79%, and Enveric Biosciences Inc (ENVB) at USD 1.58 up 4.29%.

More News

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike faces scrutiny over cost-cutting ahead of first investor day since 2017

Nike is under pressure to clarify its cost-cutting plans as it prepares for its first investor day since 2017, scheduled for November 16–17. Despite efforts led by CEO Elliott Hill to turn the company around, management expects revenue to decline by ...

Market News
Bearish
55 minutes ago
Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric launch North America's first plug-in virtual power plant for renters in NYC.

Jackery and Every Electric have partnered to create North America's first plug-and-play virtual power plant (VPP) for renters and apartment residents, starting in New York City. This innovative system uses portable power stations plugged into standar...

Market News
Bullish
1 hour ago
P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI names retired Brig. Gen. Matt Isler GM for Aerospace and Defense to boost AI engineering efforts.

P-1 AI has appointed retired Brigadier General Matt Isler as General Manager for its Aerospace and Defense division. Isler brings nearly 30 years of military and industry experience, including leadership roles at Northrop Grumman and startup DEFCON A...

Market News
Bullish
1 hour ago
Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo renews share buyback plan to repurchase up to 10% of public shares by Nov 2027

Saputo Inc. has renewed its Normal Course Issuer Bid (NCIB), allowing it to repurchase up to 22.5 million common shares, representing 10% of its public float, from November 19, 2026, to November 18, 2027. This move reflects Saputo's strategy to retur...

Company Fundamentals
Bullish
2 hours ago
GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian expands program to alert companies of leaked credentials, boosting enterprise cybersecurity worldwide.

GitGuardian has launched the Enterprise Good Samaritan Program to identify and notify companies about high-impact leaked credentials that could expose their systems to attackers. Using AI and expert analysis, the program traces leaks to affected orga...

Market News
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App